NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » Resurgence of Mycoplasma pneumoniae post Covid-19 Pandemic

Thermo Fisher Scientific - Here for reliable molecular diagnostics

White Paper

Resurgence of Mycoplasma pneumoniae post Covid-19 Pandemic

January 31, 2024

The rising cases of Mycoplasma pneumoniae post-COVID-19 pandemic are a cause for concern. Learn about the resurgence of this pathogen and the importance of accurate and rapid diagnostic testing in our latest whitepaper.

Download to find out more.

Download White Paper